Science without
compromise.
A research-first biotechnology company working at the frontier of programmable biology — building the tools, the experiments, and the therapies that turn what we call incurable into what we call solvable.
Therapeutic focus
Genetic medicine
Core platforms
CRISPR · mRNA · AAV
Research model
Wet-lab + computational
Operating principle
Open by default
Every condition we currently call incurable is a problem the science hasn't finished solving yet — and that finishing is the work.
— The Nexin Biotech research charter
Six domains, one integrated lab.
Our work sits at the intersection of molecular biology, delivery science, and the brain. We share methods and findings publicly so the field can examine, challenge, and extend them.
All research areas
What's moving the field.
A curated read of research news — from inside Nexin and across the global biotech community.
How we work
Programmable biology, at human resolution.
From a single base pair to a whole organism — our research connects molecular precision to clinical meaning. The principles below shape every program we run.
01
Hypothesis first
Every program begins as a falsifiable claim, pre-registered before the first experiment runs.
02
Mechanism over outcome
We invest in understanding why a therapy works, not only that it does.
03
Iteration in weeks
Tight wet-lab and computational loops keep ideas moving at the speed of evidence.
04
Open by default
Methods, negative results, and reagents shared so the field can challenge and extend our work.
How we work matters as much as what we build.
Ambition this large demands proportional care. We commit to patients, our people, and the planet — not as initiatives, but as the conditions under which we agree to do the work.
Our commitmentsPatients
Access, affordability, and clinical trial equity sit at the center of every program decision.
People
A scientific culture built on rigor, mentorship, and intellectual honesty — long before headlines.
Planet
Sustainable lab operations, responsible sourcing, and transparent reporting on our footprint.
Research updates, the moment they go out.
New publications, program milestones, and rare announcements — delivered to your inbox. No noise, no marketing.
Newsletter
Research updates, no fluff.
A short, periodic note when we publish new work or kick off a new program.
One email at a time. Unsubscribe anytime.